Can automated sample prep systems be validated for regulated industries?

Yes, automated sample preparation systems can be validated for regulated industries. Validation is not only possible but increasingly expected by regulatory bodies and accreditation standards. The key is demonstrating that the automated system performs with the same rigor, reproducibility, and accuracy as a manual method, and in many cases, automation makes that easier to prove.

For laboratories working under frameworks such as ISO 17025, EU food safety regulations, or US EPA methods, a validated automated sample prep workflow must meet defined acceptance criteria for recovery, precision, and selectivity. The good news is that modern automated cleanup and extraction platforms are specifically engineered to meet these demands, often outperforming manual procedures in reproducibility and traceability.

Below, this article works through the most common questions laboratories ask when evaluating automated sample preparation validation, from regulatory requirements to timelines and multi-matrix flexibility.

What does method validation actually require for automated systems?

Method validation for automated sample preparation systems requires demonstrating that the system consistently produces results that meet predefined performance criteria. These criteria typically include accuracy (expressed as recovery), precision (repeatability and reproducibility), selectivity, linearity, the limit of detection, and robustness. For automated systems, validation must show that the system itself does not introduce variability or bias.

In practice, this means running a structured set of experiments using certified reference materials or spiked samples across the relevant concentration range. Each run must be documented with full traceability: instrument settings, solvent volumes, timing, and operator records. Automated systems have a clear advantage here: their programmable parameters are fixed and logged, which means the validation data directly reflects the method as it will be used in routine analysis.

Key validation parameters for automated sample prep include:

Recovery: The percentage of analyte retrieved after extraction and cleanup, typically assessed using isotopically labeled internal standards
Repeatability: Variation across replicate samples prepared in the same run
Reproducibility: Variation across different runs, operators, or days
Selectivity: The ability to isolate target analytes from matrix interferences
Robustness: Performance stability when minor parameters (solvent lot, sample mass) are deliberately varied

For contaminants such as dioxins, PCBs, and PFAS, the acceptance criteria are often defined by the applicable regulatory method, for example, EU Commission Regulation 2023/915 for dioxins in food and feed, or EPA Method 1613B for PCDD/Fs. The validation data must show the automated system meets those criteria under realistic laboratory conditions.

Which regulatory frameworks govern sample prep validation?

Several regulatory frameworks govern how sample preparation methods must be validated in regulated industries. The most widely applicable is ISO/IEC 17025, the international standard for testing and calibration laboratory competence, which requires all methods, including automated sample prep, to be validated before use. Beyond ISO 17025, the specific requirements depend on the analytical target and the regulatory jurisdiction.

For laboratories analyzing persistent organic pollutants in food and feed across Europe, EU Commission Regulation 2023/915 and its predecessors set performance criteria that sample preparation workflows must satisfy. US EPA methods such as EPA 1613B (dioxins and furans), EPA 1668 (PCBs), and EPA 537.1 (PFAS in drinking water) each define method-specific validation requirements that apply directly to the sample preparation stage.

Other relevant frameworks include:

SANTE guidelines for pesticide residue analysis in food and feed (EU)
Codex Alimentarius guidelines for method performance criteria in food analysis
ICH Q2(R2) for pharmaceutical applications requiring analytical procedure validation
EURACHEM/CITAC guidance on method validation in analytical chemistry, widely referenced by ISO 17025-accredited labs

What these frameworks share is a requirement for documented evidence of performance. Automated systems that generate electronic audit trails, fixed program parameters, and logged run data are well positioned to satisfy these documentation requirements, often more completely than manual workflows.

How do automated sample prep systems demonstrate reproducibility across runs?

Automated sample preparation systems demonstrate reproducibility by eliminating the operator-dependent variability that is the primary source of run-to-run inconsistency in manual methods. Because solvent volumes, contact times, flow rates, and sequence steps are programmed and executed identically in every run, the system itself becomes the controlled variable, and its performance can be measured and documented with precision.

Reproducibility is assessed by running the same validated method across multiple days, ideally with different operators and different reagent lots, and comparing the results. For dioxin and PCB analysis, for example, isotopically labeled recovery standards are added before cleanup and measured in the final extract. The consistency of those recovery values across runs is a direct measure of the system’s reproducibility.

Automated platforms also support reproducibility through features such as:

Fixed, programmable solvent volumes that eliminate pipetting error
Controlled flow rates and contact times that are not subject to operator fatigue or distraction
Sample-to-system isolation that prevents cross-contamination between runs
Electronic run logs that make deviations immediately visible and traceable

Published peer-reviewed work has demonstrated the reproducibility of fully automated sample preparation for dioxins and PCBs. Fujita et al. (2016) presented validation data for a fully automated system covering simultaneous analysis of dioxins, PCBs, and PBDEs, showing that automated cleanup delivers consistent recoveries that meet regulatory acceptance criteria across multiple matrices and run sequences.

Can a single automated system be validated for multiple matrices?

Yes, a single automated sample preparation system can be validated for multiple matrices, but each matrix requires its own validation data. The system’s mechanical and chemical performance may be identical across matrices, but the matrix itself introduces different co-extractants, lipid loads, moisture content, and interference profiles, all of which affect recovery and selectivity. Validation must demonstrate acceptable performance in each matrix where the method will be used.

In practice, this means a laboratory validating an automated cleanup system for dioxin analysis in food would need separate validation sets for, say, fish oil, animal fat, and plant-based feed, even if the same program is used for all three. The validation data for each matrix is then documented and referenced in the laboratory’s quality system.

The advantage of automated systems in multi-matrix validation is efficiency. Once the core method is established and the system is qualified, extending validation to a new matrix typically requires fewer experiments than building a new manual method from scratch. The system’s fixed parameters mean that matrix-specific adjustments, such as a modified pre-treatment step or a different lipid removal protocol, can be introduced and validated incrementally.

Modern automated GO-EHT cleanup systems are designed to handle exactly this kind of matrix diversity. They are capable of processing food, feed, soil, sewage sludge, water, and air samples within the same platform, making multi-matrix validation a realistic and structured process rather than a prohibitive one.

What’s the difference between system qualification and method validation?

System qualification and method validation are two distinct but complementary processes. System qualification confirms that the instrument itself is installed correctly, operates within its design specifications, and performs consistently over time. Method validation confirms that a specific analytical method, run on that qualified system, produces results that are fit for their intended purpose. Both are required in regulated laboratories, but they answer different questions.

System qualification is typically structured around four phases:

Design Qualification (DQ): Confirms the system design meets the laboratory’s requirements before purchase
Installation Qualification (IQ): Confirms the system is installed correctly and all components are present and functional
Operational Qualification (OQ): Confirms the system operates within defined parameters across its operational range
Performance Qualification (PQ): Confirms the system performs consistently under routine operating conditions over time

Method validation, by contrast, is performed on a qualified system and focuses on the analytical method’s performance characteristics, recovery, precision, selectivity, linearity, and robustness, for a specific analyte in a specific matrix. A method validated on an unqualified instrument carries no regulatory weight, which is why qualification must come first.

For automated sample preparation, the distinction matters practically: a laboratory that has qualified its automated cleanup platform can then validate multiple methods on that same system without repeating the qualification process, provided the system remains in its qualified state and maintenance records are current.

How long does it take to validate an automated sample prep method?

Validating an automated sample preparation method typically takes between four and twelve weeks, depending on the complexity of the method, the number of matrices, and the regulatory framework that defines the acceptance criteria. Simple, single-matrix methods with well-established acceptance criteria can be validated in a few weeks. Multi-matrix methods targeting multiple compound classes under strict regulatory requirements may take several months.

The main factors that influence validation timeline are:

Number of analytes and matrices: Each combination requires its own dataset
Availability of certified reference materials: Reference standards for compounds like PCDD/Fs or specific PFAS congeners can have long lead times
Regulatory acceptance criteria: More stringent criteria require more replicate experiments to demonstrate compliance
Laboratory workload: Validation experiments must be scheduled around routine analysis commitments
Prior method development: A well-developed method reaches validation faster than one still being optimized

Automated systems can shorten the overall timeline compared to manual methods because the fixed parameters reduce the number of experiments needed to demonstrate reproducibility. When a system’s operating conditions are locked and logged, fewer replicates are typically needed to achieve statistical confidence in the precision data. Additionally, laboratories that partner with suppliers offering method development support can accelerate both the development and validation phases by drawing on existing application data for the same or similar matrices.

How DSP-Systems supports automated sample prep validation

DSP-Systems works directly with laboratories navigating the validation process for automated sample preparation systems. Whether a laboratory is implementing an automated cleanup platform for the first time or extending an existing validated method to a new matrix, DSP-Systems provides the technical foundation to do it efficiently and in compliance with applicable regulatory standards.

Validated system configurations: Systems such as the GO-EHT and SPE2000 are supplied pre-configured and tested against EPA and CEN method requirements, giving laboratories a qualified starting point for validation
Method development and validation support: DSP-Systems actively supports laboratories with method development across dioxins, PCBs, PBDEs, PFAS, pesticides, PAHs, and more, including ISO 17025-compliant documentation
Analytical standards: A comprehensive range of isotopically labeled and native certified reference materials is available, including complete standard kits for GO-EHT applications covering calibration, spiking, cleanup, and recovery standards
Multi-matrix expertise: With experience across food, feed, soil, water, sludge, and air matrices, DSP-Systems brings application knowledge that shortens the path from system installation to validated routine use
Outsourced analysis during transition: Laboratories can outsource analyses to ISO 17025-accredited partner labs while building or validating internal capacity

If your laboratory is evaluating automated sample preparation validation or needs support implementing a compliant workflow, contact DSP-Systems to discuss your specific requirements and how the right system configuration can be matched to your regulatory context.

Veelgestelde vragen

Do we need to revalidate our automated sample prep method if we upgrade or replace the system?

Not necessarily a full revalidation, but you will need to perform a comparability or bridging study to demonstrate that the new or upgraded system produces equivalent results to the previously validated configuration. This typically involves running a defined set of reference samples on both systems and comparing recovery, precision, and selectivity data against the original acceptance criteria. If the system change is significant, such as a different platform or a fundamental change in chemistry, a more comprehensive revalidation may be required under ISO 17025 and applicable regulatory frameworks. Always document the change and the rationale for the revalidation scope in your quality system.

What certified reference materials (CRMs) do we need to have in place before starting validation?

At a minimum, you will need isotopically labeled internal standards for recovery assessment, native certified reference materials at known concentrations for accuracy testing, and ideally a certified matrix reference material that matches your target sample type. For dioxin and PCB analysis, this means compound-specific 13C-labeled standards for each congener group being measured, along with CRMs such as those available from NIST, LGC, or Wellington Laboratories. PFAS validation requires its own labeled analog set aligned with the target congener list in methods like EPA 537.1. Sourcing these materials early is critical, as some standards have significant lead times that can delay your validation timeline.

Can an automated sample prep method validated in-house be accepted by external auditors or accreditation bodies?

Yes, provided the validation is documented in accordance with the requirements of the applicable accreditation standard, most commonly ISO/IEC 17025. Accreditation bodies such as UKAS, DAkkS, or A2LA assess whether the validation data demonstrates fitness for purpose, not whether the method is manual or automated. In fact, automated systems often fare well in audits because their electronic run logs, fixed parameters, and traceable records directly satisfy the documentation requirements assessors look for. The key is ensuring your validation report includes all required performance parameters, references the applicable regulatory method or standard, and is maintained as a controlled document within your quality management system.

What are the most common reasons automated sample prep validations fail or need to be repeated?

The most frequent causes of validation failure are insufficient recovery for specific analytes in high-fat or complex matrices, unacceptable variability in precision data due to inadequate method development before validation begins, and incomplete documentation that cannot satisfy audit requirements. Starting validation before the method is fully optimized is a particularly common and costly mistake, as poor recovery or high variability at the validation stage typically means returning to method development. Using inappropriate or non-certified reference materials, failing to include enough replicates to achieve statistical confidence, and not accounting for matrix-specific interferences in the selectivity assessment are also recurring issues that can invalidate an otherwise well-executed study.

How do we handle matrix-matched calibration when validating an automated cleanup method for multiple sample types?

Matrix-matched calibration is used when matrix effects are known to influence instrument response after cleanup, and it requires preparing calibration standards in a representative blank matrix that has undergone the same automated extraction and cleanup procedure as real samples. For multi-matrix validation, this means preparing separate matrix-matched calibration curves for each matrix type, which adds experimental work but is often required under frameworks such as SANTE guidelines for pesticide residues or EU regulations for dioxins. Isotopically labeled internal standards added before extraction are the preferred approach for compensating for matrix effects in high-resolution mass spectrometry methods, as they track analyte behavior through the entire automated workflow and reduce the dependence on matrix-matched calibration.

Is it possible to validate an automated sample prep method for analytes where no regulatory acceptance criteria exist yet?

Yes, and this situation is increasingly common for emerging contaminants such as novel PFAS compounds or new pesticide metabolites. When no regulatory acceptance criteria are defined, laboratories typically apply fit-for-purpose criteria derived from recognized guidance documents such as EURACHEM, Codex Alimentarius, or SANTE, selecting recovery and precision targets appropriate to the concentration range and intended use of the results. The validation report should clearly state the basis for the chosen acceptance criteria and justify why they are appropriate for the intended application. This approach is generally accepted by ISO 17025 accreditation bodies, provided the rationale is documented and the criteria are technically defensible.

How should we manage ongoing performance verification after the initial validation is complete?

Ongoing performance verification, sometimes called method performance monitoring or quality control charting, is required to demonstrate that a validated automated method remains in a state of control during routine use. This typically involves running certified reference materials or spiked quality control samples at defined intervals, tracking recovery and precision values on control charts, and investigating any results that fall outside established warning or action limits. For automated sample prep systems, the electronic run logs provide a built-in layer of ongoing traceability, but they do not replace analytical QC. Periodic system requalification, scheduled according to your maintenance plan and the manufacturer’s recommendations, is also necessary to confirm the instrument remains within its qualified operating state over time.

Gerelateerde artikelen

Deze inhoud is gegenereerd met behulp van AI en kan fouten bevatten.